Дисферлинопатии: проблема за пределами дистальных миопатий
https://doi.org/10.17650/2222-8721-2012-0-2-20-28
Аннотация
Список литературы
1. Miyoshi K., Jap J. Hum Genet 1967;12:113
2. Miyoshi K., Kawai H., Iwasa M. et al. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case. Brain 1986;109:31−54.
3. Bashir R., Britton S., Strachan T. et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer‑1 is mutated in limb‑girdle muscular dystrophy type 2B. Nat Genet 1998;20:37−42.
4. Liu J., Aoki M., Illa I. et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20: 31−6.
5. Illa I., Serrano‑Munuera C., Gallardo E. et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001;49:130–4.
6. Nguyen K., Bassez G., Krahn M. et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 2007;64:1176−82.
7. Aoki M., Liu J., Richard I. et al. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology 2001;57:271−8.
8. Diers A., Carl M., Stoltenburg‑Didinger G. et al. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF. Neuromuscul Disord 2007;17:157−62.
9. Eymard B., Laforêt P., Tomé F.M. et al. Miyoshi distal myopathy: specific signs and incidence. Rev Neurol (Paris) 2000;156:161−8.
10. Weiler T., Greenberg C.R., Nylen E. et al. Limb‑girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Am J Hum Genet 1996;59:873−8.
11. Illarioshkin S.N., Ivanova‑Smolenskaya I.A., Tanaka H. et al. Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy. Brain 1996;119:1895−909.
12. Fanin M., Nascimbeni A.C., Aurino S. et al. Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes. Neurology 2009;72:1432−5.
13. Paradas C., González‑Quereda L., De Luna N. et al. A new phenotype of dysferlinopathy with congenital onset. Neuromuscul Disord 2009;19:21–5.
14. Wenzel K., Geier C., Qadri F. et al. Dysfunction of dysferlin-deficient hearts. J Mol Med 2007;85:1203−14.
15. Paradas C., Llauger J., Diaz‑Manera J. et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 2010;75:298−9.
16. Spuler S., Carl M., Zabojszcza J., et al. Dysferlin-deficient muscular dystrophy features amyloidosis. Ann Neurol 2008; 63(3):323−8.
17. Rosales X.Q., Gastier‑Foster J.M., Lewis S. et al. Novel diagnostic features of dysferlinopathies. Muscle Nerve 2010;42:14−21.
18. Kawabe K., Goto K., Nishino I. et al. Dysferlin mutation analysis in a group of Italian patients with limb‑girdle muscular dystrophy and Miyoshi myopathy. Eur J Neurol 2004;11:657−61.
19. Krahn M., Beroud C., Labelle V. et al. Analysis of the DYSF mutational spectrum in a large cohort of patients. Hum Mutat 2009;30:E345−75.
20. Bansal D., Miyake K., Vogel S.S. et al. Defective membrane repair in dysferlindeficient muscular dystrophy. Nature 2003; 423:168−72.
21. De Morrée A., Hensbergen P.J., van Haagen H.H. et al. Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity. PLoS One 2010; 5:e13854.
22. Linssen W.H., Notermans N.C., Van der Graaf Y. et al. Miyoshi‑type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients. Brain 1997;120:1989−96.
23. Hicks D., Sarkozy A., Muelas N. et al. A founder mutation in Anoctamin 5 is a major cause of limb‑girdle muscular dystrophy. Brain 2011;134:171−82.
24. Rawat R., Cohen T.V., Ampong B., et al. Inflammasome up‑regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol 2010;176:2891−900.
25. Krahn M., Wein N., Bartoli M. et al. A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy. Sci Transl Med 2010;2:50−69.
26. Han R., Frett E.M., Levy J.R. et al. Genetic ablation of complement C3 attenuates muscle pathology in dysferlindeficient mice. J Clin Invest 2010; 120(12):4366−74,
27. Choi E.R., Choi E.R., Park S.J. et al. Early detection of cardiac involvement in Miyoshi myopathy: 2D strain echocardiography and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;2:12−31.
Рецензия
Для цитирования:
Urtizberea J. Дисферлинопатии: проблема за пределами дистальных миопатий. Нервно-мышечные болезни. 2012;(2):20-28. https://doi.org/10.17650/2222-8721-2012-0-2-20-28
Просмотров: 918
Послать статью по эл. почте 